Live Price
Live Volume
Chart Volume 0
Volume 0
5 secOutlook Therapeutics Market Segments
Premarket
+0.0050(+0.76%)
| Open | $0.6606 |
|---|---|
| Close | $0.6656 |
| Low | $0.6435 |
| Low Change | -0.0171 (-2.59%) |
| High | $0.6700 |
| High Change | +0.0094 (+1.42%) |
| Range | $0.0265 |
| Volume | 44.37K |
| Dollar Volume | $29.53K |
Overnight
+0.0000(+0.00%)
| Open | $0.6463 |
|---|---|
| Close | $0.6463 |
| Low | $0.6463 |
| Low Change | 0.0000 (0.00%) |
| High | $0.6463 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0000 |
| Volume | 602 |
| Dollar Volume | $389.07 |
After Hours Yesterday
-0.0152(-2.30%)
| Open | $0.6612 |
|---|---|
| Close | $0.6460 |
| Low | $0.6460 |
| Low Change | -0.0152 (-2.30%) |
| High | $0.6649 |
| High Change | +0.0037 (+0.56%) |
| Range | $0.0189 |
| Volume | 86.254K |
| Dollar Volume | $55.72K |
Regular Trading Hours Yesterday
+0.0233(+3.67%)
| Open | $0.6348 |
|---|---|
| Close | $0.6581 |
| Low | $0.6260 |
| Low Change | -0.0088 (-1.39%) |
| High | $0.6700 |
| High Change | +0.0352 (+5.55%) |
| Range | $0.0440 |
| Volume | 2.82M |
| Dollar Volume | $1.86M |
Premarket Yesterday
-0.0105(-1.63%)
| Open | $0.6436 |
|---|---|
| Close | $0.6331 |
| Low | $0.6249 |
| Low Change | -0.0187 (-2.91%) |
| High | $0.6663 |
| High Change | +0.0227 (+3.53%) |
| Range | $0.0414 |
| Volume | 118.713K |
| Dollar Volume | $75.16K |
Outlook Therapeutics News
1 month agoinvesting.comWhy is Outlook Therapeutics stock plunging today?
- 2 months agoinvesting.com
Why is Outlook Therapeutics stock surging today?
- 3 months agoinvesting.com
Outlook Therapeutics stock surges on FDA BLA resubmission
- 4 months agoinvesting.com
Outlook Therapeutics stock surges after winning FDA appeal
- 8 months agoinvesting.com
Baidu, ASML, furniture stocks rise; Outlook Therapeutics sinks
- 8 months agoinvesting.com
Outlook Therapeutics stock plunges after FDA rejects wet AMD drug application
Outlook Therapeutics Top Trades
Outlook Therapeutics's top trade so far today returned +3.43%, while the top short trade returned -2.59%.
Outlook Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.6516 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.6435 |
| 20 Day Moving Average (SMA20) | $0.6674 |
| 50 Day Moving Average (SMA50) | $1.0392 |
| 100 Day Moving Average (SMA100) | $0.8751 |
| 200 Day Moving Average (SMA200) | $0.8467 |
Outlook Therapeutics Statistics
| Average Volume (30 Days) | 18.11M |
|---|---|
| P/E Ratio (Current) | -3.20 |
| EPS (Current) | -$0.20 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$56.15M |
| Cash Ratio | 0.39 |
| Current Ratio | 0.81 |
| Quick Ratio | 0.63 |
| Debt to Equity | -1.75 |
| Enterprise Value | $162.30M |
| EV to EBITDA | -4.25 |
| EV to Sales | -151.44 |
| Price to Book | -14.94 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | -144.92 |
| Return on Assets | -1.83% |
| Return on Equity | 4.60% |
Outlook Therapeutics Stock Splits
There have been 2 stock splits for Outlook Therapeutics (OTLK). The last reverse stock split occured on March 14, 2024 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 14, 2024 | Reverse | 20:1 |
| Mar 18, 2019 | Reverse | 8:1 |
Outlook Therapeutics Dividends
There have been no dividends for Outlook Therapeutics (OTLK).